Medical Devices Startups
6,185 companies tagged Medical Devices, with their investors and founders.
greenteg develops and manufactures certified heat flux and temperature sensors in Switzerland, including its CORE/calera gSKIN technology, which are integrated into wearables for health monitoring, sports, medtech, and building U-value measurement. Founded as a spin-off of ETH Zurich, it serves engineers, scientists, research teams, and consumer wearable partners worldwide.</parameter> <parameter name="founders">[]
2 investors
GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery. The technique is intended to support weight loss and glycemic control in obese patients with or without type 2 diabetes, and its products have received FDA marketing authorization and clearances.
2 investors
H3D builds an AI platform called AutoDesign that automates the design of custom-fit products, replacing manual CAD work for hearing labs (hearing aids, hearing protection, consumer audio) and dental labs. The company serves labs globally in the medical device and consumer technology industries, using AI, 3D, image processing and cloud computing.
2 investors
Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery. The device targets retained blood syndrome and the need for surgical re-exploration in cardiac surgery patients.
2 investors
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders. Its lead technology, SynthoPlate, is a fully-synthetic hemostatic agent that acts at the injury site to amplify the body's natural clotting mechanisms.
2 investors
HanchorBio is a biotech company developing innovative immunotherapy drugs for cancer treatment through translational medicine, moving from early research to clinical applications.
2 investors
Hanimune Therapeutics develops therapeutics for food allergy prevention and tolerance support for pediatric and adult patients, drawing on immunological science and food protein research.
2 investors
Haplotype Labs develops population genetics software and polygenic risk scores with improved security, accessibility, and sophistication to enhance human healthspan. The company serves researchers, healthcare providers, and consumers seeking genetic risk assessment tools.
2 investors
Headsafe is a brain health technology company whose product, Nurochek, is an FDA-cleared portable brain scanner that uses Visual Evoked Potentials and proprietary algorithms to deliver objective concussion assessment in about two minutes without a baseline. It serves emergency departments, sports medicine programs, neurology practices, urgent care centers, and imaging facilities.
2 investors
Healing Innovations develops robotic rehabilitation technology aimed at improving health, mobility, and independence for people recovering from neurological injuries. It works with patients, clinical staff, and partners to provide neuro rehabilitation solutions.
2 investors
Healium Digital Healthcare develops AI-powered point-of-care ultrasound technology that non-invasively detects chronic kidney disease (CKD) at early stages and identifies its root cause using digital biomarkers. Its tools generate patient-specific perfusion models and 3D kidney representations, supporting nephrologists and healthcare professionals in CKD screening, diagnosis, and progression monitoring.
2 investors
Spectrumedics develops the Sonico-CX intravascular lithotripsy (shockwave) system for treating calcified coronary artery disease, delivering 360° circumferential shockwave pulses through a low-profile catheter. The medical device company serves interventional cardiologists and has received regulatory approval to market its product.
2 investors
HealthCube manufactures portable point-of-care diagnostic devices that can screen for 55+ health parameters including vitals, biochemical, cardiac, and infectious disease markers. The company serves remote and underserved healthcare settings globally, with a focus on India's rural and tier-3 locations.
2 investors
A healthcare-focused investment firm managing approximately $2 billion in assets across 52 portfolio companies. The firm invests in commercial-stage healthcare companies including services, IT, medical devices, diagnostics, and pharma services.
2 investors
hearX develops mobile applications for hearing screening and monitoring using validated audio testing technology. The company serves the general public and healthcare providers with affordable, clinically-backed hearing assessment tools.
2 investors
Hello Inside sells continuous glucose monitoring (CGM) sensors for 14-day glucose tracking. The company operates with country-specific sensor models due to regulatory requirements.
2 investors
Hememics develops FAST (Functionalized Analyte Screening Technology), an immunoassay-based screening platform that lets researchers use their own antibodies and antigens to screen antibody mini-panels in under an hour. Positioned as a faster, lower-cost alternative to ELISA, it delivers digital end-point results using a 96-well plate and a compatible reader.
2 investors
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants. It targets clinicians, patients, and public health programs in emerging and resource-limited markets, with significant operations and manufacturing in India.
2 investors
HeRO Graft is a fully subcutaneous arteriovenous access device for hemodialysis patients with central venous stenosis, designed to reduce infection rates and improve long-term vascular access reliability. The product combines an ePTFE arterial graft component with a silicone venous outflow component for dialysis treatment.
2 investors
HepaTx develops stem cell-based hepatocyte therapies for liver disease treatment as an alternative to organ transplantation. The company targets niche liver disease indications including alpha-1 antitrypsin deficiency, phenylketonuria, and non-alcoholic steatohepatitis.
2 investors
HEPHAISTOS is a biopharmaceutical company developing third-generation innate immune boosters (TLR4 agonists) that convert myeloid-rich, immunotherapy-resistant tumors into immunotherapy-responsive tumors. Its lead candidate HEPHA440 targets front-line cancer therapy and is scheduled to enter clinical trials in 2027.
2 investors
A fertility diagnostics company offering semen analysis testing services across multiple locations in North America.
2 investors
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
2 investors
Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
2 investors